Search, analyze & compare

My selected companies

Adjust valuation method
WatchlistNameTickerP/EP/SP/BEV/EbitdaROEROICRSISMA200DCFVolumeClosing price
-
Collegium Pharmaceutical IncCOLL11.111.644.434.7042.89%5.08%40.60$31.47$35.4943,190$30.50

Detail of Collegium Pharmaceutical Inc

 
CEO
Mr. Vikram Karnani
Employees
197
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Market cap
$984M

Company details

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, and oral formulation of oxycodone for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; Belbuca, a buccal film that contains buprenorphine; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.

Revenue
Cost of goods
Gross profit
OE
G&A
OI
OIE
PI
TAX
NI
Revenue (Rev)
$599.24M
Cost of goods (CoG)
-$225.56M
Gross profit (GP)
$373.69M
Operating expense (OE)
-$180.21M
General and administrative (G&A)
-$180.21M
Operating income (OI)
$193.47M
Other income expense (OIE)
-$11.33M
Pretax income (PI)
$128.01M
Tax (TAX)
-$39.42M
Net income (NI)
$88.59M
Collegium Pharmaceutical Inc
COLL • XNGS • US
$30.50
+1.35 (4.63%)
Stock vs Industry average
  • Industry average

Trailing annual dividend rate
$0.00
Payout ratio
0.00%
EPS
$2.75
Margin profit
14.78%
52 week low
$28.985001
52 week high
$41.880001
50-day simple moving average
$30.53
200-day simple moving average
$31.47
Percent held by insiders
1.64%
Percent held by institutions
121.86%
Dividend yield
0.00%

Change of shares

Cash vs Debt

Insider Trading

Comparison of selected companies

 
%
Price change
COLL +2.87%
eps change
COLL -52.46%